Article Text

Download PDFPDF
Interleukin 10 Polymorphisms and Cervical Cancer Risk: A Meta-Analysis
  1. Jing Ni, MD*,
  2. Yang Ye, PhD,
  3. Fang Teng, MD and
  4. Qiang Wu, PhD*
  1. *Department of Gynecologic Oncology, Jiangsu Cancer Hospital and Research Institute;
  2. Department of Molecular Cell Biology and Toxicology, School of Public Health, Nanjing Medical University; and
  3. Department of Gynaecology and Obstetrics, Nanjing Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Nanjing, China.
  1. Address correspondence and reprint requests to Qiang Wu, PhD, Department of Gynecologic Oncology, Jiangsu Cancer Hospital and Research Institute, 42 Baiziting, Nanjing 210009, China. E-mail: wqjsch{at}126.com.

Abstract

Background A debate exists about whether interleukin 10 (IL-10) polymorphisms (IL-10−1082G/A and IL-10−592C/A) confer additional risk for cervical cancer. To derive a more precise estimation of the relationship between IL-10 polymorphisms and cervical cancer risk, we conducted a meta-analysis of all available studies relating the −1082G/A and −592C/A polymorphisms of the IL-10 gene to the risk of developing cervical cancer.

Methods Eight studies were eligible for IL-10 −1082G/A (1498 cases and 1608 controls), and 5 studies were eligible for IL-10 −592C/A (2396 cases and 1388 controls). Pooled odds ratios (ORs) were appropriately derived from fixed-effects or random-effects models. Subgroup analyses were performed by ethnicity and Hardy-Weinberg equilibrium in the controls.

Results In the overall analysis, no significant association between the IL-10−1082G/A polymorphism and the risk of cervical cancer was observed. In the subgroup analysis by ethnicity, IL-10 −1082A allele was associated with decreased cervical cancer susceptibility among whites (A vs G: OR, 0.39; 95% confidence interval [CI], 0.32–0.47). Studies with controls deviated from Hardy-Weinberg equilibrium showed an evident association in dominant model (GA/AA vs GG: OR, 1.73 [95% CI, 1.04–2.89]). On the other hand, with respect to −592C/A polymorphism, significantly elevated cervical cancer risk was found in the overall analysis (A vs C: OR, 1.16 [95% CI, 1.04–1.31]; AA vs CC: OR, 1.36 [95% CI, 1.00–1.84]; CA/AA vs CC: OR, 1.18 [95% CI, 1.01–1.39]; AA vs CC/CA: OR, 1.25 [95% CI, 1.01–1.55]). Stratified analysis indicated that significantly increased risks were also found among Asians in the allelic model (A vs C: OR, 1.23 [95% CI, 1.01–1.49]).

Conclusions Interleukin 10−1082 G/A polymorphism showed no effect on cervical cancer risk in the overall analysis. The genetic polymorphism in IL-10−592C/A is a risk factor for developing cervical cancer, especially for Asians.

  • IL-10
  • Cervical cancer
  • Polymorphism
  • Meta-analysis

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • The study was supported by grant from the Jiangsu Provincial Department of Sciences and Technology (BS2006072).

  • Drs Ni and Ye contributed equally to this work.

  • The authors declare no conflicts of interest.